Human Adipose Tissue is considered as a new source for Stromal Stem Cells and offers a large therapeutic potential for many rare and common diseases that impacts millions of patients worldwide. The Stromal Vascular Fraction (SVF) of Adipose Tissue is relatively easy to extract with minimally invasive procedures such as elective liposuction in large quantities and therefore may be a cost effective source for cellular therapies in a wide range of medical specialties. In this study we aim to demonstrate the efficacy of Antria Cell Preparation Process© in obtaining human adipose derived Stromal Vascular Fraction (SVF) by performing histology, various cell counts, multiple surface marker tests and measurement of the residual amount of digestive enzymes as a safety measure for human clinical trials.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
4
Elective Liposuction
Blair Plastic Surgery
Altoona, Pennsylvania, United States
Indiana Regional Medical Center
Indiana, Pennsylvania, United States
• To assess the success rate of our methodology in extraction of SVF from adipose tissue by performing cell count, cell viability tests and specific surface markers
Time frame: one month
To compare the effectiveness of 2 different digestive enzymes in randomly selected set of samples
Time frame: one month
To measure the amount of residual digestive enzyme after the procedure
Time frame: one month
To determine the time and cost of supply during the procedure
Time frame: one month
To conclude logistic barriers (transport and testing of cells)
Time frame: one month
Obtaining cultures to detect potential contamination by pathogenes
Time frame: one month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.